Coexistence of the Oxazolidinone Resistance-Associated Genes and in From a Healthy Piglet in Brazil.

Oxazolidinones are one of the most important antimicrobials potentially active against glycopeptide- and β-lactam-resistant Gram-positive pathogens. Linezolid-the first oxazolidinone to be approved for clinical use in 2000 by the US Food and Drug Administration-and the newer molecule in the class, tedizolid, inhibit protein synthesis by suppressing the formation of the 70S ribosomal complex in bacteria. Over the past two decades, transferable oxazolidinone resistance genes, in particular and , have been identified in Firmicutes isolated from healthcare-related infections, livestock, and the environment.